Evidence Hub

Effect of Serum Vitamin B12 Levels on Premature Ejaculation

Sonbahar AE, Culha MG

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2024

62 participants · 3 citations

Abstract

OBJECTIVE

To assess the impact of vitamin B12 levels in the failure of the dapoxetine used in premature ejaculation (PE) treatment.

STUDY DESIGN

Experimental study. Place and Duration of the Study: Andrology Clinic, between May and December 2020.

METHODOLOGY

Patients with premature ejaculation complaints completed the Premature Ejaculation Diagnostic Tool (PEDT) questionnaire. Patients were also asked to fill in the Premature Ejaculation Profile (PEP) surveys. Intravaginal ejaculation latency time (IELT) were recorded based on the estimates of patients. Serum vitamin B12 levels were evaluated based on blood samples. All patients were advised to use dapoxetine 30 mg, 1-3 hours prior to intercourse. After four weeks, patients were asked to complete the PEP questionnaire again. IELT times were recorded.

RESULTS

A total of 62 patients were included in the study. A total of 39 patients (62.90%) were satisfied with the treatment of the dapoxetine. In comparison to patients who benefited from dapoxetine treatment and those who did not, vitamin B12 levels of patients who did not benefit from dapoxetine were found to be significantly lower (p=0.005).

CONCLUSION

Vitamin B12 deficiency can reduce the effectiveness of dapoxetine treatment in patients with PE. It is important to evaluate serum vitamin B12 levels for the evaluation of patients with PE.

KEY WORDS

Premature ejaculation, Dapoxetine, Vitamin B12, Serotonin, Treatment.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free